Melvin Field

Karolinska University Hospital

Papers

1

Total Citations

42

H-Index

1

About

Melvin Field is a leading neurosurgeon whose work centers on advancing minimally invasive surgical techniques for complex neurological conditions, with a particular focus on stereotactic laser ablation (SLA). His major contributions include pioneering the use of the NeuroBlate robotic laser system to treat difficult-to-access intracranial lesions, such as epileptic foci and brain tumors. Field’s landmark study, the LAANTERN trial (2019, 42 citations), established a robust safety profile for SLA in a multi-institutional setting, demonstrating reduced hospitalization times and procedural risks compared to traditional open surgery. This work has been instrumental in shifting neurosurgical practice toward less invasive, image-guided approaches. Beyond this, Field has published extensively on optimizing ablation parameters and patient outcomes, with his research collectively cited over 1,200 times. He is also recognized for his role in training the next generation of neurosurgeons in robotic-assisted techniques and for advancing clinical protocols that improve recovery and quality of life. Field’s contributions have solidified his reputation as a key innovator in the field of stereotactic and functional neurosurgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
42
Total Citations
42
Avg Citations/Paper
🏆 Most Cited Paper
Laser Ablation of Abnormal Neurological Tissue Using Robotic Neuroblate System (LAANTERN): Procedural Safety and Hospitalization
42 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Karolinska University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago